Brandon M. York

Brandon M. York is a procurement professional specializing in the acquisition of advanced diagnostic and scientific services, with a primary focus on in-vitro diagnostic substance manufacturing, diagnostic imaging centers, and specialized professional technical services. He plays a critical role in ensuring the agency’s access to high-integrity laboratory reagents, imaging technologies, and expert analytical support, aligning acquisitions with federal standards for clinical accuracy and scientific validity. His responsibilities include managing the full lifecycle of contract actions—from market research and solicitation development to award and performance oversight—ensuring compliance with FAR and agency-specific acquisition policies. York’s contracting patterns reflect a preference for open, unrestricted competition, with no set-aside programs utilized in his recent portfolio. This indicates a focus on technical capability and performance outcomes over socioeconomic classifications, though he maintains rigorous evaluation criteria to ensure quality and reliability from all vendors. His approach prioritizes market responsiveness and innovation, often engaging with firms capable of delivering complex, regulated products and services under stringent quality control frameworks. His industry focus centers on NAICS 325413, where he procures clinical diagnostic reagents and assay kits requiring FDA clearance or approval; NAICS 621512, for imaging center services supporting diagnostic workflows; and NAICS 541990, for specialized scientific consulting, including bioanalytical validation and regulatory compliance support. These acquisitions demand deep domain expertise in laboratory medicine, medical device regulation, and clinical data standards. York collaborates with a diverse range of suppliers, including mid-to-large manufacturers of diagnostic substances, accredited imaging service providers, and niche scientific contractors with specialized technical certifications. His procurement strategy emphasizes performance-based contracting, clear statement of work development, and robust post-award surveillance to ensure consistent delivery of mission-critical capabilities.